USANA (USNA) director acquires 1,057 shares via RSU, Form 4
USANA Health Sciences (USNA) disclosed a Form 4 showing a director acquired 1,057 shares of common stock on 10/23/2025 via transaction code M, reflecting the settlement of restricted stock units into shares.
Rhea-AI Filing Summary
USANA Health Sciences (USNA) disclosed a Form 4 showing a director acquired 1,057 shares of common stock on 10/23/2025 via transaction code M, reflecting the settlement of restricted stock units into shares.
Following the transaction, the director beneficially owned 7,698 common shares directly. The filing also shows 2,115 restricted stock units beneficially owned after the event, with vesting scheduled at 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026. The derivative security price is listed as $0, consistent with RSU settlement.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,057 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,057 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- F2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did USANA (USNA) report in this Form 4?
What derivative holdings remain after the transaction for USNA?
What is the vesting schedule for the reported USANA RSUs?
What does transaction code M signify in the USNA Form 4?
Was a price paid for the derivative security conversion?
AI-generated analysis. How Rhea-AI works. Not financial advice.